They suggest that the type of IgG glycosylations in PD decrease its capacity to inhibit Fcγ-RIIIα binding, so IgG may trigger antibody-dependent cell cytotoxicity and inflammation in individuals with PD [86]. This evidence concerns the gene FCGR3A and Parkinson disease.